EPEGUTNCT07916948
Effects of Epetôme on Gastrointestinal Function, Inflammation and Wellbeing in Adults With IBS-like Symptoms (EPEGUT)
StatusNot Yet Recruiting
PhaseNot applicable
SponsorUniversity of Roehampton
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Changes in gastrointestinal symptom severity
Timeframe: baseline, week 4 and week 12
Secondary (1)
Changes in digestive comfort
Arms and interventions
(Epetōme® Synbiotic Dual Cap®)Active comparator
A dietary supplement containing fructooligosaccharides (FOS), a prebiotic fibre, combined with probiotic microorganisms in capsule form.
Placebo comparatorPlacebo comparator
Matching placebo comparator
Dietary supplements: EPEGUT, Placebo
Sites
1 site in 1 country
- University of Roehampton, School of Life and Health SciencesLondon, UK, United Kingdom